Table 2. Patient factors that influence the decision to prescribe venous thromboembolism prophylaxis in-hospital and at discharge.
Patient factor | In-hospital prophylaxis | Discharge prophylaxis | ||||
Absolute percentage difference | 95% CI | P value | Absolute percentage difference | 95% CI | P value | |
Intercept | 97.6% | 94.6% to 100% | <0.001 | 81.2% | 75.6% to 86.8% | <0.001 |
Fracture | ||||||
Nonoperative pelvis | Ref (0.0%) | Ref (0.0%) | ||||
Operative ankle | −4.0% | −6.4% to −1.7% | <0.001 | −10.0% | −14.5% to −5.4% | <0.001 |
Operative hip | −1.3% | −5.4% to 2.7% | 0.52 | 6.6% | −1.4% to 14.5% | 0.10 |
Operative proximal humerus | −10.3% | −12.6% to −7.9% | <0.001 | −53.7% | −58.3% to −49.2% | <0.001 |
Solid organ injury | ||||||
No | Ref (0.0%) | Ref (0.0%) | ||||
Yes | 1.4% | −1.0% to 43.7% | 0.26 | −0.4% | −4.9% to 4.1% | 0.86 |
Additional VTE risk factors | ||||||
No | Ref (0.0%) | Ref (0.0%) | ||||
Yes | 1.5% | −0.8% to 3.8% | 0.21 | 11.9% | 7.4% to 16.4% | <0.001 |
Health insurance status | ||||||
Employer-based | Ref (0.0%) | Ref (0.0%) | ||||
Uninsured | −2.4% | −4.8% to −0.1% | 0.04 | −1.2% | −5.7% to 3.4% | 0.62 |
The values presented are based on the weighted sample.
VTEvenous thromboembolism